nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—ADRB3—type 2 diabetes mellitus	0.253	0.566	CbGaD
Norepinephrine—ADRA2A—type 2 diabetes mellitus	0.114	0.256	CbGaD
Norepinephrine—CYP1A2—type 2 diabetes mellitus	0.0794	0.178	CbGaD
Norepinephrine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0431	0.121	CbGbCtD
Norepinephrine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0392	0.11	CbGbCtD
Norepinephrine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0371	0.104	CbGbCtD
Norepinephrine—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0337	0.0946	CbGbCtD
Norepinephrine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0314	0.088	CbGbCtD
Norepinephrine—SLC22A3—Metformin—type 2 diabetes mellitus	0.0261	0.0733	CbGbCtD
Norepinephrine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0258	0.0724	CbGbCtD
Norepinephrine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0248	0.0695	CbGbCtD
Norepinephrine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0238	0.0667	CbGbCtD
Norepinephrine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0155	0.0434	CbGbCtD
Norepinephrine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.014	0.0393	CbGbCtD
Norepinephrine—SLC22A1—Metformin—type 2 diabetes mellitus	0.0134	0.0377	CbGbCtD
Norepinephrine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.011	0.0309	CbGbCtD
Norepinephrine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0104	0.0292	CbGbCtD
Norepinephrine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00711	0.0199	CbGbCtD
Norepinephrine—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00642	0.229	CbGeAlD
Norepinephrine—Lactic acidosis—Glyburide—type 2 diabetes mellitus	0.00441	0.0842	CcSEcCtD
Norepinephrine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00258	0.0921	CbGeAlD
Norepinephrine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00174	0.0619	CbGeAlD
Norepinephrine—Aggression—Glimepiride—type 2 diabetes mellitus	0.00149	0.0284	CcSEcCtD
Norepinephrine—Pallor—Bromocriptine—type 2 diabetes mellitus	0.00142	0.0271	CcSEcCtD
Norepinephrine—PAH—kidney—type 2 diabetes mellitus	0.00123	0.044	CbGeAlD
Norepinephrine—Pallor—Gliclazide—type 2 diabetes mellitus	0.00117	0.0223	CcSEcCtD
Norepinephrine—Aggression—Gliclazide—type 2 diabetes mellitus	0.0011	0.021	CcSEcCtD
Norepinephrine—Sweating—Nateglinide—type 2 diabetes mellitus	0.00105	0.02	CcSEcCtD
Norepinephrine—SLC6A2—nerve—type 2 diabetes mellitus	0.000976	0.0348	CbGeAlD
Norepinephrine—Blood pressure increased—Gliclazide—type 2 diabetes mellitus	0.000968	0.0185	CcSEcCtD
Norepinephrine—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.000929	0.23	CrCbGaD
Norepinephrine—DRD2—nerve—type 2 diabetes mellitus	0.000889	0.0317	CbGeAlD
Norepinephrine—Blood pressure increased—Valsartan—type 2 diabetes mellitus	0.000889	0.017	CcSEcCtD
Norepinephrine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000885	0.0316	CbGeAlD
Norepinephrine—ADRB3—adipose tissue—type 2 diabetes mellitus	0.000867	0.0309	CbGeAlD
Norepinephrine—PAH—liver—type 2 diabetes mellitus	0.000778	0.0278	CbGeAlD
Norepinephrine—Blood pressure increased—Irbesartan—type 2 diabetes mellitus	0.000764	0.0146	CcSEcCtD
Norepinephrine—Arrhythmia—Repaglinide—type 2 diabetes mellitus	0.000759	0.0145	CcSEcCtD
Norepinephrine—Sweating—Glipizide—type 2 diabetes mellitus	0.000751	0.0143	CcSEcCtD
Norepinephrine—Sweating—Pioglitazone—type 2 diabetes mellitus	0.000719	0.0137	CcSEcCtD
Norepinephrine—Sweating—Glimepiride—type 2 diabetes mellitus	0.000701	0.0134	CcSEcCtD
Norepinephrine—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000674	0.0129	CcSEcCtD
Norepinephrine—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.000668	0.0127	CcSEcCtD
Norepinephrine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000658	0.0235	CbGeAlD
Norepinephrine—Arbutamine—ADRB3—type 2 diabetes mellitus	0.000642	0.159	CrCbGaD
Norepinephrine—Hypertension—Repaglinide—type 2 diabetes mellitus	0.000639	0.0122	CcSEcCtD
Norepinephrine—Chest pain—Repaglinide—type 2 diabetes mellitus	0.00063	0.012	CcSEcCtD
Norepinephrine—Arrhythmia—Glipizide—type 2 diabetes mellitus	0.000628	0.012	CcSEcCtD
Norepinephrine—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.000604	0.0115	CcSEcCtD
Norepinephrine—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.000603	0.0115	CcSEcCtD
Norepinephrine—Arrhythmia—Glimepiride—type 2 diabetes mellitus	0.000586	0.0112	CcSEcCtD
Norepinephrine—SLC22A2—kidney—type 2 diabetes mellitus	0.000578	0.0206	CbGeAlD
Norepinephrine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000563	0.0201	CbGeAlD
Norepinephrine—ADRA1B—kidney—type 2 diabetes mellitus	0.000554	0.0198	CbGeAlD
Norepinephrine—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.000529	0.0101	CcSEcCtD
Norepinephrine—Hypertension—Glipizide—type 2 diabetes mellitus	0.000529	0.0101	CcSEcCtD
Norepinephrine—Anxiety—Glipizide—type 2 diabetes mellitus	0.000519	0.00991	CcSEcCtD
Norepinephrine—Sweating—Gliclazide—type 2 diabetes mellitus	0.000519	0.0099	CcSEcCtD
Norepinephrine—Headache—Tolbutamide—type 2 diabetes mellitus	0.000519	0.00989	CcSEcCtD
Norepinephrine—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000506	0.00966	CcSEcCtD
Norepinephrine—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.000499	0.00952	CcSEcCtD
Norepinephrine—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000495	0.00944	CcSEcCtD
Norepinephrine—SLC18A2—adipose tissue—type 2 diabetes mellitus	0.000494	0.0176	CbGeAlD
Norepinephrine—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000493	0.00941	CcSEcCtD
Norepinephrine—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000492	0.00938	CcSEcCtD
Norepinephrine—Anxiety—Glimepiride—type 2 diabetes mellitus	0.000485	0.00924	CcSEcCtD
Norepinephrine—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.000483	0.00922	CcSEcCtD
Norepinephrine—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000483	0.00921	CcSEcCtD
Norepinephrine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000479	0.00913	CcSEcCtD
Norepinephrine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000472	0.009	CcSEcCtD
Norepinephrine—Headache—Tolazamide—type 2 diabetes mellitus	0.000472	0.009	CcSEcCtD
Norepinephrine—Headache—Linagliptin—type 2 diabetes mellitus	0.000467	0.00891	CcSEcCtD
Norepinephrine—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000463	0.00883	CcSEcCtD
Norepinephrine—Vomiting—Acarbose—type 2 diabetes mellitus	0.00046	0.00877	CcSEcCtD
Norepinephrine—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000451	0.0086	CcSEcCtD
Norepinephrine—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000445	0.0085	CcSEcCtD
Norepinephrine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000445	0.00849	CcSEcCtD
Norepinephrine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000444	0.00846	CcSEcCtD
Norepinephrine—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000437	0.00834	CcSEcCtD
Norepinephrine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000434	0.00828	CcSEcCtD
Norepinephrine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000427	0.00814	CcSEcCtD
Norepinephrine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000416	0.00793	CcSEcCtD
Norepinephrine—Bradycardia—Metformin—type 2 diabetes mellitus	0.000414	0.00789	CcSEcCtD
Norepinephrine—SLC22A1—kidney—type 2 diabetes mellitus	0.000408	0.0146	CbGeAlD
Norepinephrine—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000402	0.0143	CbGeAlD
Norepinephrine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000391	0.00745	CcSEcCtD
Norepinephrine—SLC22A3—kidney—type 2 diabetes mellitus	0.00039	0.0139	CbGeAlD
Norepinephrine—Sweating—Losartan—type 2 diabetes mellitus	0.000386	0.00736	CcSEcCtD
Norepinephrine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000384	0.00732	CcSEcCtD
Norepinephrine—Headache—Repaglinide—type 2 diabetes mellitus	0.000378	0.00722	CcSEcCtD
Norepinephrine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000375	0.00715	CcSEcCtD
Norepinephrine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000372	0.00709	CcSEcCtD
Norepinephrine—Droxidopa—ADRB3—type 2 diabetes mellitus	0.000369	0.0914	CrCbGaD
Norepinephrine—DRD2—retina—type 2 diabetes mellitus	0.000368	0.0131	CbGeAlD
Norepinephrine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000368	0.0131	CbGeAlD
Norepinephrine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000365	0.00697	CcSEcCtD
Norepinephrine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00036	0.00687	CcSEcCtD
Norepinephrine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000359	0.00685	CcSEcCtD
Norepinephrine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000358	0.00682	CcSEcCtD
Norepinephrine—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000354	0.0127	CbGeAlD
Norepinephrine—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.000352	0.0126	CbGeAlD
Norepinephrine—SLC18A2—liver—type 2 diabetes mellitus	0.000346	0.0124	CbGeAlD
Norepinephrine—SLC22A5—retina—type 2 diabetes mellitus	0.000343	0.0122	CbGeAlD
Norepinephrine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000343	0.00654	CcSEcCtD
Norepinephrine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000343	0.00654	CcSEcCtD
Norepinephrine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000337	0.012	CbGeAlD
Norepinephrine—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.000335	0.0831	CrCbGaD
Norepinephrine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000334	0.0119	CbGeAlD
Norepinephrine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000334	0.00637	CcSEcCtD
Norepinephrine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000331	0.00631	CcSEcCtD
Norepinephrine—Sweating—Ramipril—type 2 diabetes mellitus	0.000331	0.00631	CcSEcCtD
Norepinephrine—Anxiety—Valsartan—type 2 diabetes mellitus	0.00033	0.00629	CcSEcCtD
Norepinephrine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000327	0.00624	CcSEcCtD
Norepinephrine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000326	0.00621	CcSEcCtD
Norepinephrine—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000323	0.0115	CbGeAlD
Norepinephrine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000323	0.00615	CcSEcCtD
Norepinephrine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000318	0.0113	CbGeAlD
Norepinephrine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000318	0.00606	CcSEcCtD
Norepinephrine—Headache—Glipizide—type 2 diabetes mellitus	0.000313	0.00597	CcSEcCtD
Norepinephrine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000308	0.00587	CcSEcCtD
Norepinephrine—Hypertension—Metformin—type 2 diabetes mellitus	0.000306	0.00583	CcSEcCtD
Norepinephrine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000303	0.00578	CcSEcCtD
Norepinephrine—Chest pain—Metformin—type 2 diabetes mellitus	0.000301	0.00575	CcSEcCtD
Norepinephrine—Headache—Pioglitazone—type 2 diabetes mellitus	0.0003	0.00572	CcSEcCtD
Norepinephrine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000296	0.00565	CcSEcCtD
Norepinephrine—ADRA2C—kidney—type 2 diabetes mellitus	0.000296	0.0106	CbGeAlD
Norepinephrine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000296	0.00564	CcSEcCtD
Norepinephrine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000294	0.0105	CbGeAlD
Norepinephrine—Headache—Glimepiride—type 2 diabetes mellitus	0.000292	0.00557	CcSEcCtD
Norepinephrine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000291	0.00555	CcSEcCtD
Norepinephrine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000289	0.0103	CbGeAlD
Norepinephrine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000288	0.0055	CcSEcCtD
Norepinephrine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000284	0.00542	CcSEcCtD
Norepinephrine—SLC22A5—kidney—type 2 diabetes mellitus	0.000284	0.0101	CbGeAlD
Norepinephrine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000283	0.00541	CcSEcCtD
Norepinephrine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000283	0.00539	CcSEcCtD
Norepinephrine—Epinephrine—ADRB3—type 2 diabetes mellitus	0.000282	0.0698	CrCbGaD
Norepinephrine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.00028	0.01	CbGeAlD
Norepinephrine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000279	0.00533	CcSEcCtD
Norepinephrine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000277	0.00528	CcSEcCtD
Norepinephrine—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000276	0.00987	CbGeAlD
Norepinephrine—Chest pain—Losartan—type 2 diabetes mellitus	0.000268	0.0051	CcSEcCtD
Norepinephrine—Methyldopa—ADRA2A—type 2 diabetes mellitus	0.000268	0.0663	CrCbGaD
Norepinephrine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000267	0.0051	CcSEcCtD
Norepinephrine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000267	0.00953	CbGeAlD
Norepinephrine—Anxiety—Losartan—type 2 diabetes mellitus	0.000267	0.00509	CcSEcCtD
Norepinephrine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000264	0.00503	CcSEcCtD
Norepinephrine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000264	0.00503	CcSEcCtD
Norepinephrine—SLC22A1—liver—type 2 diabetes mellitus	0.000258	0.00922	CbGeAlD
Norepinephrine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000258	0.00491	CcSEcCtD
Norepinephrine—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000256	0.00913	CbGeAlD
Norepinephrine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000248	0.00473	CcSEcCtD
Norepinephrine—SLC22A3—liver—type 2 diabetes mellitus	0.000247	0.00881	CbGeAlD
Norepinephrine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000244	0.00466	CcSEcCtD
Norepinephrine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000243	0.00464	CcSEcCtD
Norepinephrine—Headache—Glyburide—type 2 diabetes mellitus	0.000241	0.00459	CcSEcCtD
Norepinephrine—Levonordefrin—ADRA2A—type 2 diabetes mellitus	0.000237	0.0587	CrCbGaD
Norepinephrine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000235	0.00839	CbGeAlD
Norepinephrine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.00023	0.00822	CbGeAlD
Norepinephrine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000229	0.00438	CcSEcCtD
Norepinephrine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000229	0.00436	CcSEcCtD
Norepinephrine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000229	0.00436	CcSEcCtD
Norepinephrine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00022	0.00419	CcSEcCtD
Norepinephrine—Headache—Gliclazide—type 2 diabetes mellitus	0.000216	0.00413	CcSEcCtD
Norepinephrine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000213	0.00761	CbGeAlD
Norepinephrine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000213	0.00406	CcSEcCtD
Norepinephrine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000202	0.00385	CcSEcCtD
Norepinephrine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000199	0.0038	CcSEcCtD
Norepinephrine—Headache—Valsartan—type 2 diabetes mellitus	0.000199	0.00379	CcSEcCtD
Norepinephrine—ADRA1A—liver—type 2 diabetes mellitus	0.000197	0.00702	CbGeAlD
Norepinephrine—Headache—Orlistat—type 2 diabetes mellitus	0.000196	0.00375	CcSEcCtD
Norepinephrine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000196	0.00374	CcSEcCtD
Norepinephrine—Phenylephrine—CYP1A2—type 2 diabetes mellitus	0.000191	0.0473	CrCbGaD
Norepinephrine—ADRA2C—liver—type 2 diabetes mellitus	0.000187	0.00669	CbGeAlD
Norepinephrine—Vomiting—Metformin—type 2 diabetes mellitus	0.000184	0.0035	CcSEcCtD
Norepinephrine—Headache—Metformin—type 2 diabetes mellitus	0.000181	0.00345	CcSEcCtD
Norepinephrine—SLC22A5—liver—type 2 diabetes mellitus	0.000179	0.0064	CbGeAlD
Norepinephrine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000173	0.00331	CcSEcCtD
Norepinephrine—Headache—Irbesartan—type 2 diabetes mellitus	0.000171	0.00326	CcSEcCtD
Norepinephrine—Droxidopa—ADRA2A—type 2 diabetes mellitus	0.000167	0.0414	CrCbGaD
Norepinephrine—Vomiting—Losartan—type 2 diabetes mellitus	0.000163	0.00311	CcSEcCtD
Norepinephrine—CYP1A2—liver—type 2 diabetes mellitus	0.000163	0.0058	CbGeAlD
Norepinephrine—Headache—Losartan—type 2 diabetes mellitus	0.000161	0.00307	CcSEcCtD
Norepinephrine—Vomiting—Ramipril—type 2 diabetes mellitus	0.00014	0.00267	CcSEcCtD
Norepinephrine—Headache—Ramipril—type 2 diabetes mellitus	0.000138	0.00263	CcSEcCtD
Norepinephrine—Salbutamol—CYP3A4—type 2 diabetes mellitus	0.00013	0.0322	CrCbGaD
Norepinephrine—Epinephrine—ADRA2A—type 2 diabetes mellitus	0.000128	0.0316	CrCbGaD
Norepinephrine—Epinephrine—TNF—type 2 diabetes mellitus	0.000121	0.03	CrCbGaD
Norepinephrine—Dopamine—CYP1A2—type 2 diabetes mellitus	9.08e-05	0.0225	CrCbGaD
Norepinephrine—Epinephrine—CYP1A2—type 2 diabetes mellitus	8.86e-05	0.022	CrCbGaD
Norepinephrine—Epinephrine—CYP3A4—type 2 diabetes mellitus	5.87e-05	0.0145	CrCbGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.23e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.23e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.23e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.23e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.23e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.22e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.22e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.22e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.22e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.21e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.21e-06	1.96e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.21e-06	1.96e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.2e-06	1.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.19e-06	1.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.19e-06	1.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.18e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.18e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.18e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.18e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	2.18e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.17e-06	1.93e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.16e-06	1.92e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.15e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	2.14e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.14e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.14e-06	1.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—INS—type 2 diabetes mellitus	2.13e-06	1.9e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.12e-06	1.89e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.12e-06	1.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	2.11e-06	1.88e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.1e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	2.1e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.1e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.1e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	2.09e-06	1.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.08e-06	1.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.07e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	2.07e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.07e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.07e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.07e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.07e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.06e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.06e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	2.06e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.06e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.06e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.05e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	2.05e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.04e-06	1.81e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.04e-06	1.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.04e-06	1.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.03e-06	1.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.03e-06	1.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.03e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.03e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.02e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.02e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.02e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.02e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.01e-06	1.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2e-06	1.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2e-06	1.78e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.98e-06	1.76e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.98e-06	1.76e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.96e-06	1.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.96e-06	1.74e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.95e-06	1.73e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	1.94e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.93e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.91e-06	1.7e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.9e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.9e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.9e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.9e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.89e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.88e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.87e-06	1.67e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.87e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.87e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.87e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.87e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.86e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.86e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.86e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.84e-06	1.64e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.84e-06	1.64e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.83e-06	1.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.82e-06	1.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.82e-06	1.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.81e-06	1.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.8e-06	1.6e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.8e-06	1.6e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.79e-06	1.6e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.78e-06	1.58e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.78e-06	1.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.76e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.76e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.75e-06	1.56e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.75e-06	1.56e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.75e-06	1.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.73e-06	1.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.73e-06	1.54e-05	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.73e-06	1.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.73e-06	1.54e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.72e-06	1.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.72e-06	1.53e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.72e-06	1.53e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.71e-06	1.52e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.7e-06	1.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.7e-06	1.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.7e-06	1.51e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.7e-06	1.51e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.7e-06	1.51e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.7e-06	1.51e-05	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.69e-06	1.51e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.69e-06	1.5e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	1.69e-06	1.5e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.68e-06	1.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.68e-06	1.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.67e-06	1.49e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.67e-06	1.49e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.67e-06	1.48e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.67e-06	1.48e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	1.48e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.64e-06	1.46e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.64e-06	1.45e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.64e-06	1.45e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.63e-06	1.45e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.62e-06	1.44e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.61e-06	1.43e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.6e-06	1.43e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.6e-06	1.43e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.6e-06	1.42e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.6e-06	1.42e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.6e-06	1.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.59e-06	1.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.59e-06	1.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.59e-06	1.41e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.59e-06	1.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.58e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.58e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.57e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.57e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.57e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.56e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.56e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.56e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.56e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.55e-06	1.38e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.54e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.54e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.52e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.52e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.52e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.5e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.5e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.5e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.49e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.48e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.47e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.46e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.46e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.46e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.46e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.45e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.44e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.44e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.44e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.44e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.43e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.43e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.43e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.42e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.41e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.4e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.39e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.38e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.38e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.37e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.36e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.36e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.35e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.35e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.34e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.34e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.34e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.33e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.32e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.32e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.32e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.31e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.31e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.3e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.3e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.3e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.29e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.28e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.28e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.27e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.26e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.24e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.22e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.22e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.22e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.21e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.21e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.21e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.19e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.18e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.17e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.14e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-06	1e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.12e-06	9.99e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.11e-06	9.83e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.1e-06	9.79e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	9.74e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.08e-06	9.62e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.06e-06	9.43e-06	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	9.41e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.05e-06	9.33e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	9.15e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-06	9.07e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-06	8.96e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1e-06	8.94e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1e-06	8.92e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1e-06	8.92e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	9.98e-07	8.88e-06	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	9.86e-07	8.77e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.85e-07	8.76e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.85e-07	8.76e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	9.32e-07	8.29e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.29e-07	8.27e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.21e-07	8.19e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	9.18e-07	8.16e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	9.17e-07	8.16e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.09e-07	8.09e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.6e-07	7.65e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.46e-07	7.53e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.46e-07	7.52e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	8.35e-07	7.43e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.15e-07	7.25e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.8e-07	6.94e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.57e-07	6.74e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.52e-07	6.69e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.99e-07	6.21e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.61e-07	4.1e-06	CbGpPWpGaD
